BMRN vs CLDX · P/E 40, rev $1.76B vs rev $37.0K
Biomarin Pharmaceutical Inc (BMRN) versus Celldex Therapeutics Inc (CLDX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CLDX currently screens at market cap $2.35B.
Not investment advice. Open the BMRN and CLDX stock pages for the full models.
Not investment advice.